Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer's Global R&D Network: Rapid Integration Means Doing More With Less

This article was originally published in The Pink Sheet Daily

Executive Summary

Even as the drug maker cuts its R&D budget and staff, there are plans to maintain productivity and hit key diseases hard.

You may also be interested in...



Merck Looks Beyond First-In-Class Only As It Seeks To Bolster R&D Productivity

With three large outcomes studies to read out interim or final results, 2012 is likely to be a pivotal year for Merck’s R&D, even as it rebalances its traditionally first-in-class emphasis to a hybrid model that also embraces best in class.

Merck Looks Beyond First-In-Class Only As It Seeks To Bolster R&D Productivity

With three large outcomes studies to read out interim or final results, 2012 is likely to be a pivotal year for Merck’s R&D, even as it rebalances its traditionally first-in-class emphasis to a hybrid model that also embraces best in class.

AstraZeneca Rebuilds Its R&D, With Payers In Mind

When Martin Mackay joined AstraZeneca PLC as president, global research & development, from Pfizer Inc. one year ago, one of his objectives was to "put AstraZeneca's R&D back on the map."

Related Content

Topics

UsernamePublicRestriction

Register

PS068736

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel